133 related articles for article (PubMed ID: 29976640)
21. Analysis of KIAA1549-BRAF fusion status in a case of rosette-forming glioneuronal tumor of the fourth ventricle (RGNT).
Gessi M; Waha A; Setty P; Waha A; Pietsch T
Neuropathology; 2011 Dec; 31(6):654-7. PubMed ID: 21518014
[TBL] [Abstract][Full Text] [Related]
22. A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.
Tomić TT; Olausson J; Wilzén A; Sabel M; Truvé K; Sjögren H; Dósa S; Tisell M; Lannering B; Enlund F; Martinsson T; Åman P; Abel F
PLoS One; 2017; 12(4):e0175638. PubMed ID: 28448514
[TBL] [Abstract][Full Text] [Related]
23. Sensitive determination of BRAF copy number in clinical samples by pyrosequencing.
Setty P; Gessi M; Waha A; Hammes J; El-Maarri O; Pietsch T; Waha A
Diagn Mol Pathol; 2011 Sep; 20(3):148-57. PubMed ID: 21817898
[TBL] [Abstract][Full Text] [Related]
24. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
25. Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.
Lee RP; Foster KA; Lillard JC; Klimo P; Ellison DW; Orr B; Boop FA
J Neurosurg Pediatr; 2017 Sep; 20(3):247-255. PubMed ID: 28686121
[TBL] [Abstract][Full Text] [Related]
26. The prognostic role of intragenic copy number breakpoints and identification of novel fusion genes in paediatric high grade glioma.
Carvalho D; Mackay A; Bjerke L; Grundy RG; Lopes C; Reis RM; Jones C
Acta Neuropathol Commun; 2014 Feb; 2():23. PubMed ID: 24548782
[TBL] [Abstract][Full Text] [Related]
27. BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum.
Faulkner C; Ellis HP; Shaw A; Penman C; Palmer A; Wragg C; Greenslade M; Haynes HR; Williams H; Lowis S; White P; Williams M; Capper D; Kurian KM
J Neuropathol Exp Neurol; 2015 Sep; 74(9):867-72. PubMed ID: 26222501
[TBL] [Abstract][Full Text] [Related]
28. Molecular Analysis of Tumor Cell Components in Pilocytic Astrocytomas, Gangliogliomas, and Oligodendrogliomas.
Mesturoux L; Durand K; Pommepuy I; Robert S; Caire F; Labrousse F
Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):496-500. PubMed ID: 27389560
[TBL] [Abstract][Full Text] [Related]
29. BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma.
Koelsche C; Sahm F; Paulus W; Mittelbronn M; Giangaspero F; Antonelli M; Meyer J; Lasitschka F; von Deimling A; Reuss D
Neuropathol Appl Neurobiol; 2014 Apr; 40(3):337-44. PubMed ID: 23822828
[TBL] [Abstract][Full Text] [Related]
30. Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms.
Davis JL; Vargas SO; Rudzinski ER; López Marti JM; Janeway K; Forrest S; Winsnes K; Pinto N; Yang SE; VanSandt M; Boyd TK; Corless CL; Liu YJ; Surrey LF; Harris MH; Church A; Al-Ibraheemi A
Histopathology; 2020 Jun; 76(7):1032-1041. PubMed ID: 31994201
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal mutational analysis of a cerebellar pilocytic astrocytoma recurring as a ganglioglioma.
Fiset PO; Fontebasso AM; De Jay N; Gayden T; Nikbakht H; Majewski J; Jabado N; Albrecht S
Pediatr Blood Cancer; 2017 Feb; 64(2):275-278. PubMed ID: 27718322
[TBL] [Abstract][Full Text] [Related]
32. A new NFIA:RAF1 fusion activating the MAPK pathway in pilocytic astrocytoma.
Yde CW; Sehested A; Mateu-Regué À; Østrup O; Scheie D; Nysom K; Nielsen FC; Rossing M
Cancer Genet; 2016 Oct; 209(10):440-444. PubMed ID: 27810072
[TBL] [Abstract][Full Text] [Related]
33. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
[TBL] [Abstract][Full Text] [Related]
34. Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age.
Fontebasso AM; Shirinian M; Khuong-Quang DA; Bechet D; Gayden T; Kool M; De Jay N; Jacob K; Gerges N; Hutter B; Şeker-Cin H; Witt H; Montpetit A; Brunet S; Lepage P; Bourret G; Klekner A; Bognár L; Hauser P; Garami M; Farmer JP; Montes JL; Atkinson J; Lambert S; Kwan T; Korshunov A; Tabori U; Collins VP; Albrecht S; Faury D; Pfister SM; Paulus W; Hasselblatt M; Jones DT; Jabado N
Oncotarget; 2015 Oct; 6(31):31844-56. PubMed ID: 26378811
[TBL] [Abstract][Full Text] [Related]
35. [Clinicopathological Study of Pilomyxoid-Spectrum Astrocytomas:An Analysis of the BRAF Gene. Report of Two Cases].
Ito T; Sato K; Oikawa M; Sugio H; Asanome T; Ozaki Y; Nakamura H; Tanaka S; Tsuda M; Nagashima K
No Shinkei Geka; 2015 Sep; 43(9):825-33. PubMed ID: 26321697
[TBL] [Abstract][Full Text] [Related]
36. Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma?
Sie M; de Bont ES; Scherpen FJ; Hoving EW; den Dunnen WF
Neuropathol Appl Neurobiol; 2010 Dec; 36(7):636-47. PubMed ID: 20704656
[TBL] [Abstract][Full Text] [Related]
37. Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population.
Trabelsi S; Chabchoub I; Ksira I; Karmeni N; Mama N; Kanoun S; Burford A; Jury A; Mackay A; Popov S; Bouaouina N; Ben Ahmed S; Mokni M; Tlili K; Krifa H; Yacoubi MT; Jones C; Saad A; H'mida Ben Brahim D
Mol Neurobiol; 2017 May; 54(4):2381-2394. PubMed ID: 26957305
[TBL] [Abstract][Full Text] [Related]
38. A comparative analysis of MAPK pathway hallmark alterations in pilocytic astrocytomas: age-related and mutually exclusive. [corrected].
Brokinkel B; Peetz-Dienhart S; Ligges S; Brentrup A; Stummer W; Paulus W; Hasselblatt M
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):258-61. PubMed ID: 24750136
[No Abstract] [Full Text] [Related]
39. Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent.
del Bufalo F; Carai A; Figà-Talamanca L; Pettorini B; Mallucci C; Giangaspero F; Antonelli M; Badiali M; Moi L; Bianco G; Cacchione A; Locatelli F; Ferretti E; Mastronuzzi A
J Transl Med; 2014 Dec; 12():356. PubMed ID: 25524464
[TBL] [Abstract][Full Text] [Related]
40. Malignant transformation of diffuse astrocytoma to glioblastoma associated with newly developed BRAF V600E mutation.
Kanamori M; Suzuki H; Takei H; Sonoda Y; Uenohara H; Tominaga T
Brain Tumor Pathol; 2016 Jan; 33(1):50-6. PubMed ID: 26404554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
